To determine whether eradicating CSCs could sensitize HER2+ breast cancer to HER2-targeted therapy, Neu cells expressing SORE6-mcherry or SORE6-hTK were implanted into nude mice. The gene discussed is EPHB4; the disease is breast carcinoma.